MILAN, Italy--(BUSINESS WIRE)--The Sorin Group (MIL:SRN), a world leader in technologies for the treatment of cardiovascular diseases, announces the successful implant of its first uniquely-designed heart valve suitable for percutaneous procedures. The implant was performed by Prof. Axel Haverich and his team at Medizinische Hochschule in Hannover, Germany. The 78-year-old patient, who was suffering from aortic heart valve stenosis, has already left intensive care and is recovering normally, according to his physicians.
